share_log

Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst

隨着血栓意識的提高,Penumbra 準備迎接增長:分析師
Benzinga ·  12/18 00:03

Shares of Penumbra Inc (NYSE:PEN) recovered slightly in early trading on Tuesday, after a week of correction.

經過一週的修正,Penumbra Inc(紐約證券交易所代碼:PEN)的股價在週二早盤交易中小幅回升。

The Alameda, California-based company is likely to gain market share in the mechanical thrombectomy (MT) segment, according to Oppenheimer.

奧本海默表示,這家總部位於加利福尼亞州阿拉米達的公司可能會在機械血栓切除術(MT)領域獲得市場份額。

MT is a minimally invasive procedure that removes a blood clot from an artery.

Mt 是一種微創手術,可去除動脈中的血塊。

Analyst Steven Lichtman initiated coverage of Penumbra with an Outperform rating and a price target of $275.

分析師史蒂芬·利希特曼開始對Penumbra進行報道,評級爲跑贏大盤,目標股價爲275美元。

The Penumbra Thesis: The company could generate mid-teens sales growth and over 30% earnings growth, Lichtman said.

Penumbra論點:利希特曼說,該公司可以帶來十幾歲的銷售增長和超過30%的收益增長。

Check out other analyst stock ratings.

查看其他分析師的股票評級。

More than 700,000 people in the U.S. currently suffer from deep vein thrombosis (DVT) and pulmonary embolism (PE). Penumbra and its peers run clinical trials "to drive awareness" of MT benefits, Lichtman stated.

目前,美國有超過70萬人患有深靜脈血栓形成(DVT)和肺栓塞(PE)。利希特曼說,Penumbra及其同行進行臨床試驗,「以提高人們對Mt益處的認識」。

"We forecast mid-to-high teens US market growth near-term," the analyst wrote. The surgeons surveyed expect MT's share to increase to around 50% in DVT and about 60% in PE over the next few years, he added.

該分析師寫道:「我們預測美國市場在短期內將出現中高位增長。」他補充說,接受調查的外科醫生預計,在未來幾年中,MT在dvT中的份額將增加到50%左右,在PE中的份額將增加到約60%。

International thrombectomy remains an upside opportunity in the near term, Lichtman further said.

利希特曼進一步表示,國際血栓切除術在短期內仍然是一個上行機會。

Price Action: Shares of Penumbra had risen by 0.37% to $248.16 at the time of publication on Tuesday.

價格走勢:在週二發佈時,Penumbra的股價上漲了0.37%,至248.16美元。

Read More:

閱讀更多:

  • Evaluating Globus Medical: Insights From 11 Financial Analysts
  • 評估Globus Medical:來自11位財務分析師的見解

Image: Shutterstock

圖片:Shutterstock

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論